Batoclimab 680 mg SC weekly

TERMINATED · PHASE3 · Generalized Myasthenia Gravis

Sponsor Decision

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.